118 related articles for article (PubMed ID: 37170656)
1. Salvage radiotherapy after radical prostatectomy: functional outcomes in the LAPPRO trial after 8-year follow-up.
Carlsson S; Bock D; Lantz A; Angenete E; Koss Modig K; Hugosson J; Bjartell A; Steineck G; Wiklund P; Haglind E
Scand J Urol; 2023 May; 58():11-19. PubMed ID: 37170656
[TBL] [Abstract][Full Text] [Related]
2. Functional and Oncologic Outcomes Between Open and Robotic Radical Prostatectomy at 24-month Follow-up in the Swedish LAPPRO Trial.
Nyberg M; Hugosson J; Wiklund P; Sjoberg D; Wilderäng U; Carlsson SV; Carlsson S; Stranne J; Steineck G; Haglind E; Bjartell A;
Eur Urol Oncol; 2018 Oct; 1(5):353-360. PubMed ID: 31158073
[TBL] [Abstract][Full Text] [Related]
3. Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study.
Potosky AL; Davis WW; Hoffman RM; Stanford JL; Stephenson RA; Penson DF; Harlan LC
J Natl Cancer Inst; 2004 Sep; 96(18):1358-67. PubMed ID: 15367568
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical prostatectomy (GETUG-AFU 17): a randomised, phase 3 trial.
Sargos P; Chabaud S; Latorzeff I; Magné N; Benyoucef A; Supiot S; Pasquier D; Abdiche MS; Gilliot O; Graff-Cailleaud P; Silva M; Bergerot P; Baumann P; Belkacemi Y; Azria D; Brihoum M; Soulié M; Richaud P
Lancet Oncol; 2020 Oct; 21(10):1341-1352. PubMed ID: 33002438
[TBL] [Abstract][Full Text] [Related]
5. Urinary Incontinence and Erectile Dysfunction After Robotic Versus Open Radical Prostatectomy: A Prospective, Controlled, Nonrandomised Trial.
Haglind E; Carlsson S; Stranne J; Wallerstedt A; Wilderäng U; Thorsteinsdottir T; Lagerkvist M; Damber JE; Bjartell A; Hugosson J; Wiklund P; Steineck G;
Eur Urol; 2015 Aug; 68(2):216-25. PubMed ID: 25770484
[TBL] [Abstract][Full Text] [Related]
6. Preparedness for side effects and bother in symptomatic men after radical prostatectomy in a prospective, non-randomized trial, LAPPRO.
Derogar M; Dahlstrand H; Carlsson S; Bjartell A; Hugosson J; Axén E; Johansson E; Lagerkvist M; Nyberg T; Stranne J; Thorsteinsdottir T; Wallerstedt A; Haglind E; Wiklund P; Steineck G;
Acta Oncol; 2016 Dec; 55(12):1467-1476. PubMed ID: 27684933
[TBL] [Abstract][Full Text] [Related]
7. Salvage Radical Prostatectomy for Recurrent Prostate Cancer: Morbidity and Functional Outcomes from a Large Multicenter Series of Open versus Robotic Approaches.
Gontero P; Marra G; Alessio P; Filippini C; Oderda M; Munoz F; Linares E; Sanchez-Salas R; Challacombe B; Dasgupta P; Goonewardene S; Popert R; Cahill D; Gillatt D; Persad R; Palou J; Joniau S; Piechaud T; Morlacco A; Vidit S; Rouprêt M; De La Taille A; Albisinni S; Gandaglia G; Mottrie A; Joshi S; Fiscus G; Berger A; Aron M; Van Der Poel H; Tilki D; Lawrentschuk N; Murphy DG; Leung G; Davis J; Karnes RJ;
J Urol; 2019 Oct; 202(4):725-731. PubMed ID: 31075058
[TBL] [Abstract][Full Text] [Related]
8. Health outcomes after prostatectomy or radiotherapy for prostate cancer: results from the Prostate Cancer Outcomes Study.
Potosky AL; Legler J; Albertsen PC; Stanford JL; Gilliland FD; Hamilton AS; Eley JW; Stephenson RA; Harlan LC
J Natl Cancer Inst; 2000 Oct; 92(19):1582-92. PubMed ID: 11018094
[TBL] [Abstract][Full Text] [Related]
9. Quality of life impact of treatments for localized prostate cancer: cohort study with a 5 year follow-up.
Ferrer M; Guedea F; Suárez JF; de Paula B; Macías V; Mariño A; Hervás A; Herruzo I; Ortiz MJ; Ponce de León J; Sancho G; Boladeras A; Ayala A; Craven-Bratle J; Ávila M; Cunillera O; Pardo Y; Alonso J; Aguiló F;
Radiother Oncol; 2013 Aug; 108(2):306-13. PubMed ID: 23849168
[TBL] [Abstract][Full Text] [Related]
10. Radical prostatectomy versus deferred treatment for localised prostate cancer.
Vernooij RW; Lancee M; Cleves A; Dahm P; Bangma CH; Aben KK
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD006590. PubMed ID: 32495338
[TBL] [Abstract][Full Text] [Related]
11. Urinary continence after salvage radiation therapy following radical prostatectomy, assessed by a self-administered questionnaire: a prospective study.
Fontaine E; Ben Mouelli S; Thomas L; Otmezguine Y; Beurton D
BJU Int; 2004 Sep; 94(4):521-3. PubMed ID: 15329104
[TBL] [Abstract][Full Text] [Related]
12. Early and late toxicity profiles of patients receiving immediate postoperative radiotherapy versus salvage radiotherapy for prostate cancer after prostatectomy.
Vogel MME; Kessel KA; Gschwend JE; Weichert W; Wilkens JJ; Combs SE
Strahlenther Onkol; 2019 Feb; 195(2):131-144. PubMed ID: 30182246
[TBL] [Abstract][Full Text] [Related]
13. Functional and Oncological Outcomes After Open Versus Robot-assisted Laparoscopic Radical Prostatectomy for Localised Prostate Cancer: 8-Year Follow-up.
Lantz A; Bock D; Akre O; Angenete E; Bjartell A; Carlsson S; Modig KK; Nyberg M; Kollberg KS; Steineck G; Stranne J; Wiklund P; Haglind E
Eur Urol; 2021 Nov; 80(5):650-660. PubMed ID: 34538508
[TBL] [Abstract][Full Text] [Related]
14. Salvage robotic assisted laparoscopic radical prostatectomy: indications and outcomes.
Williams SB; Hu JC
World J Urol; 2013 Jun; 31(3):431-4. PubMed ID: 21104184
[TBL] [Abstract][Full Text] [Related]
15. Age at surgery, educational level and long-term urinary incontinence after radical prostatectomy.
Nilsson AE; Schumacher MC; Johansson E; Carlsson S; Stranne J; Nyberg T; Wiklund NP; Steineck G
BJU Int; 2011 Nov; 108(10):1572-7. PubMed ID: 21595820
[TBL] [Abstract][Full Text] [Related]
16. Salvage radiotherapy with or without short-term hormone therapy for rising prostate-specific antigen concentration after radical prostatectomy (GETUG-AFU 16): a randomised, multicentre, open-label phase 3 trial.
Carrie C; Hasbini A; de Laroche G; Richaud P; Guerif S; Latorzeff I; Supiot S; Bosset M; Lagrange JL; Beckendorf V; Lesaunier F; Dubray B; Wagner JP; N'Guyen TD; Suchaud JP; Créhange G; Barbier N; Habibian M; Ferlay C; Fourneret P; Ruffion A; Dussart S
Lancet Oncol; 2016 Jun; 17(6):747-756. PubMed ID: 27160475
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant and Salvage Radiotherapy after Radical Prostatectomy in Prostate Cancer Patients.
Gandaglia G; Briganti A; Clarke N; Karnes RJ; Graefen M; Ost P; Zietman AL; Roach M
Eur Urol; 2017 Nov; 72(5):689-709. PubMed ID: 28189428
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial.
Kneebone A; Fraser-Browne C; Duchesne GM; Fisher R; Frydenberg M; Herschtal A; Williams SG; Brown C; Delprado W; Haworth A; Joseph DJ; Martin JM; Matthews JHL; Millar JL; Sidhom M; Spry N; Tang CI; Turner S; Wiltshire KL; Woo HH; Davis ID; Lim TS; Pearse M
Lancet Oncol; 2020 Oct; 21(10):1331-1340. PubMed ID: 33002437
[TBL] [Abstract][Full Text] [Related]
19. Long-term functional outcomes after treatment for localized prostate cancer.
Resnick MJ; Koyama T; Fan KH; Albertsen PC; Goodman M; Hamilton AS; Hoffman RM; Potosky AL; Stanford JL; Stroup AM; Van Horn RL; Penson DF
N Engl J Med; 2013 Jan; 368(5):436-45. PubMed ID: 23363497
[TBL] [Abstract][Full Text] [Related]
20. Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial.
Parker CC; Clarke NW; Cook AD; Kynaston HG; Petersen PM; Catton C; Cross W; Logue J; Parulekar W; Payne H; Persad R; Pickering H; Saad F; Anderson J; Bahl A; Bottomley D; Brasso K; Chahal R; Cooke PW; Eddy B; Gibbs S; Goh C; Gujral S; Heath C; Henderson A; Jaganathan R; Jakobsen H; James ND; Kanaga Sundaram S; Lees K; Lester J; Lindberg H; Money-Kyrle J; Morris S; O'Sullivan J; Ostler P; Owen L; Patel P; Pope A; Popert R; Raman R; Røder MA; Sayers I; Simms M; Wilson J; Zarkar A; Parmar MKB; Sydes MR
Lancet; 2020 Oct; 396(10260):1413-1421. PubMed ID: 33002429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
